Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism: A systematic review of the literature

Endocrinology and Metabolism Clinics of North America

Volumn 31, Issue 3, 2002, Pages 619-632

  Montori, Victor M ^a   Young Jr , William F ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM CHANNEL BLOCKING AGENT; DOXAZOSIN; FLUDROCORTISONE; FUROSEMIDE; NIFEDIPINE; PRAZOSIN; RENIN; SODIUM CHLORIDE;

ALDOSTERONE BLOOD LEVEL; CLINICAL TRIAL; DATA BASE; DIAGNOSTIC ACCURACY; ESSENTIAL HYPERTENSION; HUMAN; MULTICENTER STUDY; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SALT LOADING; SCREENING TEST; STATISTICAL MODEL;

ALDOSTERONE; HUMANS; HYPERALDOSTERONISM; MASS SCREENING; RENIN;

EID: 0036713825     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(02)00013-0     Document Type: Review

References (66)

1. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients
2. Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 to 1975
3. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertensive patients
4. High incidence of primary aldosteronism in 199 patients referred with hypertension
5. Potentially high prevalence of primary aldosteronism in a primary-care population
6. Adrenocortical tumors: Recent advances in basic concepts and clinical management
7. Medical management of aldosterone-producing adenomas
8. Mineralocorticoid hypertension
9. Primary aldosteronism: A common and curable form of hypertension
10. Cochrane reviewers' handbook 4.0
11. The measurement of observer agreement for categorical data
12. How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?
13. Primary aldosteronism: Some genetic, morphological, and biochemical aspects of subtypes
14. Is the aldosterone-renin ratio useful in screening for primary aldosteronism?
15. Hyper- and hypo-aldosteronism
16. Screening and diagnosis of hypertension forms secondary to excess of mineralocorticoid
17. Pheochromocytoma and primary aldosteronism: Diagnostic approaches
18. Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients
19. Use of the saline infusion test to diagnose the cause of primary aldosteronism
20. The diagnostic value of salt depletion and salt loading in screening for secondary hypertension
21. Incidence of primary aldosteronism uncomplicated "essential" hypertension: A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria
22. Further evaluation of saline infusion for the diagnosis of primary aldosteronism
23. Primary aldosteronism: Review of diagnostic tests and 15 cases
24. Simple screening procedure for the diagnosis of primary aldosteronism
25. Clinical characteristics of primary aldosteronism: Its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital
26. Prevalence of secondary hypertension in a population sample of Swedish women
27. Use of an intravenous sodium load in screening for primary hyperaldosteronism
28. Reliability of screening methods for the diagnosis of primary aldosteronism
29. Simplified screening procedures for primary aldosteronism: Studies on the mechanism of the hyper-responsiveness to furosemide and standing
30. An easy diagnostic approach to primary aldosteronism
31. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio
32. Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: A prospective cohort follow-up study
33. Diagnosis and treatment of primary hyperaldosteronism
34. Outpatient screening tests for primary aldosteronism
35. Aldosterone to renin ratios in the evaluation of primary aldosteronism
36. Primary hyperaldosteronism: Evaluation of procedures for diagnosis and localization
37. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism
38. Plasma aldosterone-plasma renin activity ratio: A simple test to identify patients with primary aldosteronism
39. Conn's adenoma: Diagnostic and prognostic value of the measurement of potassium, renin, aldosterone levels and the aldosterone/renin ratio
40. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism
41. Is single oral administration of captopril beneficial in screening for primary aldosteronism?
42. Single oral administration of captopril may not bring an improvement in screening of primary aldosteronism
43. The aldosterone/renin ratio as a screening test for primary aldosteronism
44. Captopril v aldosterone to plasma renin activity ratio in screening for primary aldosteronism
45. The diagnosis of primary aldosteronism and separation of two major subtypes
46. Primary aldosteronism: Diagnosis and treatment
47. Primary aldosteronism: Diagnostic evaluation
48. Hyperaldosteronism is a common cause of secondary hypertension missed by primary care physicians and associated with normokalemia
49. Unexpectedly high prevalence of primary aldosteronism in a hypertension clinic population of Dundee
50. Screening for primary hyperaldosteronism in a hospital hypertensive population: Is it the commonest form of secondary hypertension?
51. Screening of selected hypertensive population for incidence of aldosterone producing adenoma: An Indian experience
52. Diagnosis of aldosterone-producing adenoma: Aldosterone/renin and adrenal venous sampling
53. The plasma aldosterone/plasma renin activity ratio at different salt intakes has a limited value for the diagnosis of primary aldosteronism
54. Primary hyperaldosteronism: A missed diagnosis in essential hypertensives?
55. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology
56. Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratio
57. Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers
58. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?
59. Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients
60. Screening of a population of young hypertensives for primary hyperaldosteronism
61. Incidence of primary hyperaldosteronism in hospitalized hypertensive patients
62. Prevalence of primary aldosteronism in the Tayside Hypertension Clinic population
63. Prevalence study on primary aldosteronism among Asian hypertensive patients in Singapore
64. Alta prevalencia de hiperaldosteronismo primario no diagnosticado en hipertension catalogados como esenciales
65. Screening for primary aldosteronism with a logistic multivariate discriminate analysis
66. Empirical evidence of design-related bias in studies of diagnostic tests